Nutritional aspects of hiv infection: The way between the wasting syndrome and the syndrome of peripheral lipodystrophy;Aspects nutritionnels de l'infection par le VIH: De la cachexie aux lipodystrophies, données récentes

Medecine et Hygiene

Volumn 57, Issue 2268, 1999, Pages 1692-1697

  Melchior, J C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006620355     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ott M, Lembcke B, Fischer H, et al. Early changes of body composition in human immunodeficiency virus-infected patients: Tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr 1993 ; 57 : 15-9.
2. Kotler DP, Wang J, Pierson R. Studies of body composition in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985 ; 42 : 1255-65.
3. Grunfeld C, Kotler DP. The wasting syndrome and nutritional support in AIDS. Semin Gastrointest Dis 1991 ; 2 : 25-36.
4. Nahlen BL, Chu SY, Nwanyanwu RL, Berkelman RL, Martinez SA, Rullan JV. HIV wasting syndrome in the United States. AIDS 1993 ; 7 : 183-8.
5. Kotler DP, Tierney AR, Wang J, Pierson RE. Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989 ; 50 : 444-7.
6. Palenicek JP, Graham NMH, He YD, et al. Weight loss prior to clinical AIDS as a predictor of survival. J Acquir Immune Defic Syndr Hum Retrovirol 1995 ; 10 : 366-73.
7. Wheeler D, Gilbert CL, Muurahainen N, et al. Weight loss as a predictor of survival and disease progression in HIV infection. J Acquir Immun Defic Syndr Hum Retrovirol 1998 ; 18 : 80-5.
8. Grunfeld C, Wilking H, Neese R, et al. Persistence of the hypertrigylceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. Cancer Res 1989 ; 49 : 2254-60.
9. Hommes MJT, Romijn JA, Endert E, et al. Insulin sensitivity and insulin clearance in human immunodeficiency virus infected men. Metabolism 1991 ; 40 : 651-6.
10. Lähdevirta J, Maury CPJ, Teppo A, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988 ; 85 : 289-91.
11. Grunfeld C, Soued M, Adi S, et al. Evidence for two classes of cytokines that stimulate hepatic lipogenesis : Relationships among tumor necrosis factor, interleukine 1 and interferon alpha. Endocrinology 1990 ; 127 : 46-54.
12. Melchior JC, Raguin G, Boulier A, et al. Resting energy expenditure in HIV infected patients. Comparison between patients with and without secondary injections. Am J Clin Nutr 1993 ; 57 : 614-20.
13. Macallan DC, McNurlan MA, Milne E, et al. Whole body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection. Am J Clin Nutr 1995 ; 61 : 818-26.
14. Macallan DC, Noble C, Baldwin C, et al. Energy expenditure and human immunodeficiency virus infection. N Engl J Med 1995 ; 333 : 83-8.
15. Martin Z, Ullrich R, Heise W, Bergs C, L'age M, Riecken EO. Malabsorption is found in early stages of HIV infection and independent of secondary infections. In : Abstracts of the Seventh International Conference on AIDS, Florence, Italy, June 16-21, 1991. Rome: Istituto Superiore di Sanità, 1991 ; 1 (Abstract) : 46.
16. Mouton Y, Alfandari S, Valette M, et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in French AIDS reference centres. AIDS 1997 ; 11 : F101-5.
17. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998 ; 12 : F51-8.
18. Vittecoq D, Escaut L, Monsuez JJ. Vascular complications associated with use of HIV protease inhibitors. Lancet 1998 ; 351 : 1959.
19. Schambelan M, Mulligan K, Grunfeld C, Daar ES, et al. Recombinant human growth hormone in patients with HIV-associated wasting. A randomised, placebo-controlled trial. Serostim study group. Ann Intern Med 1996 ; 125 : 873-82.
20. Melchior JC, Chastang C, Gelas P, et al. Efficacy of two-montn total parenteral nutrition in AIDS patients: A controlled randomised prospective trial. AIDS 1996 ; 10 : 379-84.
21. Ockenga J, Sûttmann U, Selberg O, et al. Percutaneous endoscopic gastrostomy in AIDS and control patients : Risk and outcome. Am J Gastroenterol 1996 ; 9 : 1817-22.
22. Melchior JC, Gelas P, Carbonnel F, et al. Improved survival by home total parenteral nutrition in AIDS patients: Follow-up of a controlled randomised prospective trial. AIDS 1998 ; 12 : 336-7.
23. Melchior JC, Goulet O. Nutrition et infection par le VIH. Paris: Ed. Masson, 1996.
24. Martinez E, Conget I, Lozano L, et al. Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine. AIDS 1999 ; 13 : 805-10.
25. Henry K, Melroe H, Huebesch J. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Lancet 1998 ; 352 : 1031.